Rchr
J-GLOBAL ID：200901096658652830   Update date: Jan. 30, 2024

Harashima Nanae

ハラシマ ナナエ | Harashima Nanae
Affiliation and department：
University of the Ryukyus Faculty of Medicine Health Sciences

About University of the Ryukyus Faculty of Medicine Health Sciences


Research field  (3)： Tumor biology ,  Pathobiochemistry ,  Tumor diagnostics and therapeutics
Research keywords  (4)： 腫瘍免疫学 ,  感染免疫学 ,  Immunotherapy ,  Tumor Immunology
Research theme for competitive and other funds  (11)：
  • 2018 - 2019 柑橘類由来フラボノイドを用いた ヒトがん細胞に対する抗腫瘍効果の検討
  • 2018 - 2019 がん特異的エネルギー代謝制御によるがん細胞死の誘導に関する研究
  • 2013 - 2015 癌細胞のオートファジーと低酸素応答制御による免疫的細胞傷害抵抗性の克服
  • 2011 - 2012 免疫アジュバント受容体シグナルによる癌細胞死とオートファジー
  • 2010 - 2011 上皮性癌に対するToll様受容体の役割とアポトーシス誘導経路の解明
Show all
Papers (60)：
ｍore...
MISC (129)：
  • Screening by cell-based assay of natural plant extracts as candidates for novel colorectal cancer. 2022
  • Inhibition of cell proliferation and metastasis in triple negative breast cancer cells by flavonoids. 2022
  • Growth and migration inhibitory effect of Indole-3-carbinol on human colon and breast cancer cells. 2022
  • Potential of Kalanchoe pinnata extracts in anti-colon cancer effects by inducing apoptosis. 2022
  • Anticancer and antimetastatic effect through mitochondrial-mediated intrinsic pathway in flavone-treated cancer cells. 2021. 80th
ｍore...
Patents (5)：
  • COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF NEOPLASTIC DISEASE IN A MAMMALIAN SUBJECT.
  • HLA-A11拘束性Tax抗腫瘍ペプチド
  • PEPTIDE HAVING HTLV-1-SPECIFIC CTL-INDUCING ACTIVITY
  • HTLV-1特異的CTL誘導活性ペプチド
  • PCT/JP2004/005414
Lectures and oral presentations  (3)：
  • Positive conversion of Tax specific CTL response in ATL patients after hematopoietic stem cell transplantation.
    (AIDS Res. Hum. Retroviruses 2007)
  • Major target epitopes recognized by Tax specific CTL activated in ATL patients after hematopoietic stem cell transplantation.
    (AIDS Res. Hum. Retroviruses 2005)
  • Reactivation of stromg HTLV-I-specific CTL response in ATL patients following Non-myeloablative hematopoietic stem cell transplantation.
    (AIDS Res. Hum. Retroviruses 2003)
Education (1)：
  • 1997 - 2001 Kurume University Graduate School, Division of Medicine
Work history (4)：
  • 2017/04 - 現在 University of the Ryukyus School of Health Sciences, Faculty of Medicine
  • 2007/04 - 2017/03 Shimane University Faculty of Medicine, School of Medicine
  • 2002/02 - 2007/07 Tokyo Medical and Dental University
  • 2005/07 - 2007/03 NIH, NHLBI
Committee career (2)：
  • 2011 - 現在 日本癌学会 評議員
  • 2008/01 - 現在 日本癌学会 評議員
Association Membership(s) (6)：
日本癌学会 ,  日本バイオセラピィ学会 ,  日本HTLV-1学会 ,  日本分子標的治療学会 ,  日本がん免疫学会 ,  日本免疫学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM